Correlation Between Nexgel and Utah Medical
Can any of the company-specific risk be diversified away by investing in both Nexgel and Utah Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nexgel and Utah Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nexgel Inc and Utah Medical Products, you can compare the effects of market volatilities on Nexgel and Utah Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nexgel with a short position of Utah Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nexgel and Utah Medical.
Diversification Opportunities for Nexgel and Utah Medical
-0.33 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Nexgel and Utah is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Nexgel Inc and Utah Medical Products in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Utah Medical Products and Nexgel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nexgel Inc are associated (or correlated) with Utah Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Utah Medical Products has no effect on the direction of Nexgel i.e., Nexgel and Utah Medical go up and down completely randomly.
Pair Corralation between Nexgel and Utah Medical
Given the investment horizon of 90 days Nexgel Inc is expected to generate 4.75 times more return on investment than Utah Medical. However, Nexgel is 4.75 times more volatile than Utah Medical Products. It trades about 0.15 of its potential returns per unit of risk. Utah Medical Products is currently generating about -0.09 per unit of risk. If you would invest 272.00 in Nexgel Inc on September 13, 2024 and sell it today you would earn a total of 127.00 from holding Nexgel Inc or generate 46.69% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Nexgel Inc vs. Utah Medical Products
Performance |
Timeline |
Nexgel Inc |
Utah Medical Products |
Nexgel and Utah Medical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nexgel and Utah Medical
The main advantage of trading using opposite Nexgel and Utah Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nexgel position performs unexpectedly, Utah Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Utah Medical will offset losses from the drop in Utah Medical's long position.Nexgel vs. Avita Medical | Nexgel vs. Sight Sciences | Nexgel vs. Treace Medical Concepts | Nexgel vs. Neuropace |
Utah Medical vs. Precision Optics, | Utah Medical vs. Repro Med Systems | Utah Medical vs. InfuSystems Holdings | Utah Medical vs. Milestone Scientific |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |